3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Recurrence
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Letrozole
5
Tamoxifen
4
Anastrozole
4
ribociclib
3
exemestane
3
atezolizumab
3
Vancomycin
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Injections
3
Human Papillomavirus Recombinant Vaccine nonavalent
3
Dexamethasone
3
Carboplatin
3
trametinib
2
relatlimab
2
pembrolizumab
2
encorafenib
2
dabrafenib
2
binimetinib
2
asciminib
2
Specimen Handling
2
Rituximab
2
Prednisone
2
Papillomavirus Vaccines
2
Oxaliplatin
2
Medroxyprogesterone Acetate
2
Leucovorin
2
Lenalidomide
2
Ipilimumab
2
Immune Checkpoint Inhibitors
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Propofol
×
90 days
×
Clear all
NCT06330038
2026-04-20
GASTIVA
Samsung Medical Center
Phase 4
Recruiting
5,384 enrolled